webinar recording available - register to watch

Biology's modern LIMS for labs of the future

Biotech’s lab of the future can’t wait! The potential to actualize a lab of the future is possible today with advances in technology, automation, robotics, and digitalization. These advances are reshaping how scientists run R&D labs, conduct experiments, share data and make decisions. However, legacy infrastructure and disconnected solutions are creating barriers that prevent achieving the promise of a lab of the future.

Lab of the future requires a modern, connected, adaptable solution that manages work traditionally done in siloed – and now outdated – ELN and LIMS solutions. With a shared solution connecting R&D data, teams can manage samples and processes with seamless handoffs and complete traceability. Join us for an engaging discussion with Dan Chapman, Director of the Experiment Design and Execution Platform Product at Merck, and experts from Zifo and Benchling.

In this webinar, we’ll discuss:
  • The challenges with legacy systems for today’s advanced biomolecules
  • Advantages of a modern LIMS
  • How to choose the right modern LIMS
  • Strategies to drive effective change management and adoption
watch now
watch the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Dan Chapman

Dan Chapman

Director, Product Line Leader, Merck

Dan Chapman is a software product manager and product line leader within Merck IT based in the Boston, MA area. He currently leads an internally facing product team providing products to support research and development scientists.

Prior to this, he has spent time on the vendor side working with data management and analytics products and time at the lab bench in late-stage development. He was drawn to the intersection of software and science as an Analytical Chemist in the early 2000s and didn’t look back. Dan has a bachelor’s degree in chemistry and a master’s degree in International Business Management, both from the University of Newcastle-upon-Tyne in the UK, and has over 20 years’ experience in and around the pharmaceutical industry.

Dinesh Agaram

Dinesh Agaram

Principal Consultant, Digital Transformation, Zifo

Dinesh started his career as an Innovation Lead in Bioinformatics with IBM Software Labs, following which he gained over two decades of experience in Life Sciences Digital Transformation Consulting and Change Leadership. Through this time, Dinesh has led and supported a variety of strategic initiatives in reputable organizations in the Life Sciences (Syngenta, AstraZeneca, Pfizer) and in consultancies (Cognizant, Thomson-Reuters), and has set up Data and IT teams in start-ups.

Starting recently with Zifo, Dinesh leads Consulting Practice development in Europe and is involved in pre-sales and delivery activities across the company’s client base in scientific industries.

His professional interests include reimagining the future of Automation and Data in their application to Scientific R&D, and championing robust change management principles in strategic transformation programs.

Dinesh has obtained a master’s degree in computer science from Anna University and an MBA from Cranfield.

Loren Perelman

Loren Perelman

Solutions Excellence Consultant, Benchling

Loren Perelman is a Solutions Excellence Consultant at Benchling. His career has been focused on helping organizations make better use of their primary asset, data, by improving methods of collection and utilization. Prior to Benchling, Loren was Vice President of Scientific Solutions at Riffyn, working with various customers in the Biotech and Biopharma spaces. Before Riffyn, he spent over a decade leading R&D, Process Development, and Manufacturing teams in those same spaces, with a focus on quality, analytical chemistry, and stats/modeling. His education includes a PhD in Materials Science from UCSD and a B.S. in Chemistry from Harvey Mudd College.

Arsalan Arif
moderator

Arsalan Arif

Founder & publisher, endpoints news

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.